Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Tax Provisions: 2009-2024

Historic Tax Provisions for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $343.9 million.

  • UNITED THERAPEUTICS's Tax Provisions rose 24.91% to $99.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $394.7 million, marking a year-over-year increase of 20.70%. This contributed to the annual value of $343.9 million for FY2024, which is 18.79% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Tax Provisions of $343.9 million as of FY2024, which was up 18.79% from $289.5 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Tax Provisions ranged from a high of $343.9 million in FY2024 and a low of $118.1 million during FY2021.
  • For the 3-year period, UNITED THERAPEUTICS's Tax Provisions averaged around $285.6 million, with its median value being $289.5 million (2023).
  • In the last 5 years, UNITED THERAPEUTICS's Tax Provisions surged by 305.12% in 2020 and then declined by 4.83% in 2021.
  • UNITED THERAPEUTICS's Tax Provisions (Yearly) stood at $124.1 million in 2020, then dropped by 4.83% to $118.1 million in 2021, then skyrocketed by 89.08% to $223.3 million in 2022, then grew by 29.65% to $289.5 million in 2023, then increased by 18.79% to $343.9 million in 2024.